PRIME - Advanced and versatile PRInting platform for the next generation of active Microfluidic dEvices’
Microfluidic devices manipulate tiny amounts of fluid enabling cost-effective, fast, accurate and high throughput analytical assays. Progress in Microfluidics has huge impact in environmental pollution monitoring, biohazard detection and biomedicine, contributing to the development of new tools for drug screening, biological studies, point-of-care diagnostics and personalized medicine. Despite this huge potential, Microfluidics market growth is heavily constrained by the complexity and high prices of the required large-scale off-chip equipment and its operational cost. PRIME will implement and integrate through additive manufacturing technologies light-actuated valves and pumps in a microfluidic chip. Besides inkjet printing will be used to produce new ultra sensitive and selective sensors embedded in the chip and readable with light. The final device will be remotely addressed and read using simple photonic elements that can be integrated in compact, portable and cheap operation&read devices.
Project duration: 1 May 2019 - 30 April 2023
PRIME has received funding from the European Union`s Horizon 2020 Research & Innovation Programme under grant agreement no 829010.
Role of BioNanoNet:
Within PRIME, BNN will be responsible to ensure that all knowledge created during PRIME will be disseminated to the right target groups during the whole course of the project. BNN will design the PRIME website and keep its content regularly updated.